Last update:

Gastroenterology news

Gut microbiome can reveal risk of type 2 diabetes

Changes in the composition of gut bacteria could provide an early warning of type 2 diabetes (T2D), according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) ...

Experimental gene-silencing therapy offers hope for hepatitis B cure

Chronic hepatitis B is a long-lasting condition caused by the hepatitis B virus (HBV) that affects about 240 million people worldwide. Most people infected show no symptoms for years, but when symptoms do appear, they can ...

Probiotics linked to fewer deaths in premature babies

Probiotic supplementation in very preterm babies was linked to a lower risk of both severe intestinal disease and death. This is shown by a new study from the Karolinska Institutet, published in JAMA Network Open. The findings ...

B cells may help predict risk of colitis from immunotherapy

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, adaptive immune cells, in triggering and sustaining colitis as a side effect of immune checkpoint inhibitors, ...

Why 'accidents' can happen during intense exercise

There are very few downsides to exercise. But a recent viral story highlighted one of the more embarrassing—and potentially dangerous—issues that can occur when your body reaches its limit during exercise.

Overlooked plant proteins may boost gut health

Plant-based diets are good for you. They promote gut, immune, metabolic and cardiovascular health, in part by cultivating a diverse community of intestinal bacteria. These benefits have long been known to stem partly from ...

Hepatitis E: The underestimated risk in liver cirrhosis

Infections with the hepatitis E virus (HEV) are the most common cause of acute viral hepatitis worldwide. In healthy people, they usually resolve without the person even noticing. For people with preexisting liver damage, ...

AI tool helps predict bowel cancer relapse risk

A new artificial intelligence (AI) tool developed by La Trobe University researchers could help predict which stage 2 bowel cancer patients are at risk of relapse, an advance that could ultimately lead to thousands getting ...

2008 to 2023 saw shift in causes of cirrhosis

There have been substantial epidemiological shifts in the burden of cirrhosis in the United States during the past decade, according to a study published in the American Journal of Gastroenterology.

Q&A: Cyclospora outbreak

People across the United States are taking a closer look at their lettuce and leafy greens this summer because of an outbreak of cyclosporiasis, a gastrointestinal illness whose most notable symptom is severe, watery diarrhea.